BSX Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Boston Scientific Corp. Stock Analysis BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 53,000 full-time employees. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. The company also owns the transcarotid artery revascularization (TCAR) platform.
Read More BSX Chart
Boston Scientific Corp vs S&P 500 Comparative Returns
Analysis of BSX stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Boston Scientif... (BSX...) 15.64%
- S&P 500 -4.27%
Boston Scientif... Outperformed S&P 500 by 19.91%
1Y Performance
- Boston Scientif... (BSX...) 42.04%
- S&P 500 8.86%
Boston Scientif... Outperformed S&P 500 by 33.18%
3Y Performance
- Boston Scientif... (BSX...) 169.76%
- S&P 500 37.21%
Boston Scientif... Outperformed S&P 500 by 132.55%
5Y Performance
- Boston Scientif... (BSX...) 170.53%
- S&P 500 92.3%
Boston Scientif... Outperformed S&P 500 by 78.23%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$102.97Volume
5.28MP/E Ratio (TTM)
74.8952 Week Range
Market Cap
151.86BAvg. Volume
8.02MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenue per Share (TTM) | 7 | 8.34 | 8.85 | 9.72 | - |
EBIT per Share (TTM) | 0.64 | 1.48 | 1.45 | 1.66 | - |
Earnings per Share (EPS) (TTM) | -0.08 | 0.69 | 0 | 1 | - |
Dividend per Share (TTM) | 0.02 | 0.04 | 0.04 | 0.02 | - |
EPS Forward | -0.06 | 0.73 | 0.48 | 1.09 | 1.25 |
Super Investors
View All ➜Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Ken Fisher
% Portfolio:
0.21 Recent Activity:21.56%
George Soros
% Portfolio:
0.16 Recent Activity:-71.43%
Mario Gabelli
% Portfolio:
0.12 Recent Activity:7.51%
Ron Baron
% Portfolio:
0.04 Recent Activity:-

Community-Curated Collections ( With BSX )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
Top 20 halal companies from S&P 500
By Investment Alchemist
30 Followers
Osama's List
15 Followers
My Watchlist
By Mustafa SARICA
15 Followers
A
By Mustafa SARICA
12 Followers
S&P 500 TOP 100 Halal Stock Selection (Regular updates)
By Tharawen Fridhi
6 Followers
My Watchlist
By Ahmed Ezzat
5 Followers
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.